Skip to main content

Year: 2021

Metallica Metals Announces $1.0 Million Private Placement

VANCOUVER, British Columbia, Dec. 08, 2021 (GLOBE NEWSWIRE) — Metallica Metals Corp. (CSE: MM) (OTC: MTALF) (FWB: SY7P) (the “Company” or “Metallica Metals”) is pleased to announce a non-brokered private placement (the “Private Placement”) of flow-through units of the Company (the “FT Units”) at a price of $0.18 per FT Unit. Each FT Unit consists of one (1) flow-through common share of the Company (each a “FT Common Share”) and one transferable warrant (each a “Warrant”) that is exercisable to purchase one additional common share (each a “Common Share”) at a price of $0.25 for a period of two (2) years from closing. The Company will also be issuing non-flow-through units (the “Units”) at a price of $0.15 per Unit. Each Unit consists of one (1) Common Share of the Company and one transferable Warrant that is exercisable to purchase...

Continue reading

Red Chris Exploration and Mount Polley Update

VANCOUVER, British Columbia, Dec. 08, 2021 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company”) (TSX:III) reports further drilling results continue to expand the mineralization at the East Ridge zone at the Red Chris mine. Hole RC739 returned 390 metres at 0.48% copper and 0.63 g/t gold from 1,088 metres, including 44 metres at 1.3% copper and 2.0 g/t gold from 1,402 metres. This hole is located 100 metres east of RC727 (previously reported). Hole RC745 located a further 100 metres east of RC739, returned 366 metres of 0.57% copper and 0.45 g/t gold from 728 metres, including 36 metres at 1.2% copper and 1.4 g/t gold from 960 metres. The mineralization at East Ridge is open to the east and at depth with ongoing drilling to define the extents. Brian Kynoch, President of Imperial Metals, said, “The East Ridge zone is well...

Continue reading

Rogers Communications Inc. Announces Pricing of Canadian Private Placement of $2 Billion of Fixed-to-Fixed Rate Subordinated Notes

TORONTO, Dec. 08, 2021 (GLOBE NEWSWIRE) — Rogers Communications Inc. (“RCI”) announced today that it has priced a Canadian offering of $2 billion aggregate principal amount of 5.0% fixed-to-fixed rate subordinated notes due 2081 (the “Notes”). The net proceeds from the issuance of the Notes will be approximately $1.98 billion. RCI expects to use the net proceeds of this Canadian offering to fund a portion of the cash investment required to acquire the 3500 MHz spectrum licences that it was awarded following the ISED’s spectrum auction earlier this year. The sale of the Notes is expected to close on December 17, 2021. The Notes were offered exclusively to persons resident in a Canadian province, through a syndicate of agents on a private placement basis. The Notes were not offered to investors outside of Canada. This...

Continue reading

AVCtechnologies Announces Significant Projected Revenue Growth of Kandy, its Cloud Communications Platform

ATLANTA, Dec. 08, 2021 (GLOBE NEWSWIRE) — American Virtual Cloud Technologies, Inc. (AVCtechnologies) (Nasdaq: AVCT) today announced that it projects revenues of its Kandy Business Unit to grow from $14.3 million in 2020 to approximately $18.8 million in 2021 and in excess of $37 million in 2022. The significant projected growth is driven by 505% year-over-year subscriber growth (90% CAGR) from January 2019 to today. AVCtechnologies delivers a full suite of cloud-based Unified Communications as a Service (UCaaS) capabilities to its cloud customers through its carrier-grade Kandy Business Solutions including Cloud PBX, Smart Office UC Clients, Collaboration, Contact Center, and SIP Trunks. The projected annual growth of the Kandy Business Unit comes as a result of deeper penetration with existing service provider and enterprise...

Continue reading

ibex Board of Directors Approves Share Repurchase Plan

WASHINGTON, Dec. 08, 2021 (GLOBE NEWSWIRE) — IBEX Limited (Nasdaq: IBEX) (the “Company”) today announces that its board of directors has authorized the repurchase of up to US$20 million of the Company’s common stock. “This announcement demonstrates our confidence in IBEX’s business and underlying intrinsic value,” said Bob Dechant, Chief Executive Officer at IBEX. “While we continue to focus on IBEX’s reinvestment opportunities and runway for growth, we believe that recent changes in the trading values of our shares have provided us with an opportunity to enhance our long-term value per share. We will continue to purchase our shares opportunistically at times when we believe our stock price does not reflect the intrinsic value of our company.” The Company’s proposed repurchases may be made from time to time through open market...

Continue reading

iSIGN Media Announces its interim Chief Executive Officer

TORONTO, Dec. 08, 2021 (GLOBE NEWSWIRE) — iSIGN Media Solutions Inc. (“iSIGN” or “Company”) (TSX-V: ISD) (OTC: ISDSF), a leading provider of interactive mobile proximity marketing and public security alert solutions announced the appointment of Alex Romanov as the interim Chief Executive Officer. Alex Romanov has held a variety of positions with iSIGN, most recently as Strategic Advisor to the Chief Executive Officer. Alex’s in-depth knowledge of iSIGN’s technology, combined with his longstanding relationships with iSIGN’s resellers and potential clients will prove invaluable in moving iSIGN forward with its new technology development, continued funding endeavours and attaining revenue goals. The technology team that has been working with iSIGN since June of 2021 on various improvements and enhancements to iSIGN’s existing technology...

Continue reading

Fate Therapeutics to Host Virtual Event at the 2021 ASH Annual Meeting

SAN DIEGO, Dec. 08, 2021 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that management will host a virtual event entitled “B -cell Lymphoma Franchise Update” on Tuesday, December 14, 2021 at 8:00 AM ET. The event will highlight interim Phase 1 clinical data from the Company’s FT516 and FT596 programs for the treatment of relapsed / refractory B-cell lymphomas. The live webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast will be available on the Company’s website beginning approximately two hours after the event. The...

Continue reading

Integrated Wellness Acquisition Corp Announces Pricing of $100 Million Initial Public Offering

New York, NY, Dec. 08, 2021 (GLOBE NEWSWIRE) — Integrated Wellness Acquisition Corp (the “Company”) today announced the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (“NYSE”) and will begin trading tomorrow, Thursday, December 9, 2021, under the ticker symbol “WEL.U”. Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on NYSE under the symbols “WEL” and “WEL WS,” respectively. The offering is expected to close on December 13, 2021, subject to...

Continue reading

Patria Investments Announces Launch of Growth Equity Strategy and Agreement to Partner with Kamaroopin

Growth Equity expands Patria’s coverage of the private markets investment spectrum and the agreement with Kamaroopin secures a partnership with a highly skilled investment team GRAND CAYMAN, Cayman Islands, Dec. 08, 2021 (GLOBE NEWSWIRE) — Patria Investments (“Patria”) (NASDAQ: PAX), a global alternative asset manager, announced today the launch of a new Growth Equity strategy, anchored by Kamaroopin, a private markets investment group previously affiliated with Tarpon Investments and led by Pedro Faria. The partnership is structured in two stages, first establishing a minority stake during a joint fundraising campaign, and then a full business combination contingent on fundraising success and certain other requirements. “Growth Equity is highly complementary to our flagship private equity business, and expands our product offering...

Continue reading

Aziyo Biologics Announces Closing of $14.0 Million Private Placement

SILVER SPRING, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (the “Company”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the closing of the previously announced private investment in public equity (PIPE) financing. The Company received aggregate gross proceeds of approximately $14.0 million, before deducting offering expenses. The PIPE financing was led by a fund affiliated with Birchview Capital, with participation from existing investors including funds affiliated with Deerfield Management Company and HighCape Capital. “We were pleased to see the support from Birchview Capital and our existing investors,” said Ron Lloyd, the Company’s President and CEO. “These proceeds will...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.